MD suggested late Nov going to Dec ..so may be a little wait...but who knows ... 2 news in 2 days...
3 / 3 would be nice with positive results from combo study... Tbh, I am expecting spectacular results from this study and why not....ATL1102 has been effective on its own...it can only get better from here right in the Combo trials?
Great results here would also be another positive tick for our upcoming trial and remove little doubts on its efficacy.. and also generate some interest from likes of Sarepta ...
GL...IMO..
Ann: Antisense Therapeutics CEO announces retirement, page-53
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |